/
/
/

Astrazeneca Pharma India Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)6,999.00
Volume (₹)2,583.00
High (₹)7,062.00
Upper Circuit8,328.50
Low (₹)6,905.50
Lower Circuit5,552.50
Prev Close6,940.50
52W High (₹)9,849.50
Price7,049.50
52W Low (₹)6,835.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)17367.40 Cr
Div. Yield (%)0.52
PE Ratio102.39
Debt to Equity0.00
Price to Book22.39
Book Value346.51
EPS (TTM)67.85
Face Value2.00
ROE (%)23.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ASTRAZENNSE
LTP
1W Low
1W High
Market cap (₹)
1904.6-15.4 (-0.80%)
1902
1984.80
4,56,833Cr
9189.5-49.5 (-0.54%)
9087
9467
2,45,426Cr
4900-150 (-2.97%)
4886.50
5066
1,87,320Cr
1133.4-57.6 (-4.84%)
1125.10
1187
1,13,217Cr
1390.3-33.2 (-2.33%)
1376.70
1426.10
1,12,212Cr
1852.4-86.1 (-4.44%)
1811.70
1949
1,01,155Cr
2124.4-47.1 (-2.17%)
2118.10
2192
97,626Cr
2350.7-32.2 (-1.35%)
2341.20
2419.20
96,859Cr
1163.9-14.1 (-1.20%)
1154.40
1179.90
96,406Cr
1653.5+8.2 (0.50%)
1622.60
1717
93,614Cr
7049.5-57 (-0.80%)
6835
7106.50
17,367Cr

Key Highlights of Astrazeneca Pharma India Ltd Balance Sheet

Astrazeneca Pharma India Ltd balance sheet discloses shareholders' funds of ₹5Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹5Cr, and the reserves and surplus of the company is ₹861.28Cr.

The company has its non-current liabilities with total liabilities of ₹2376.78Cr as of 2026-03-31.

The current liabilities are ₹1109.5Cr as of 2026-03-31. At the same time, current assets are ₹1859.88Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹117.47Cr, provided in the Astrazeneca Pharma India Ltd financial statements.